AMX-888

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAMX-888
Drug Alias NameC-peptide-XTENC-peptide modulator (Amunix)AMX-888
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInsulin modulators
TargetsUpdating
Therapy Area/IndicationsDiabetes ComplicationsDiabetes Mellitus, Type 1Kidney Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmunix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmunix Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDiabetes ComplicationsDiabetes Mellitus, Type 1Kidney Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A